Novel Substrates of SCF Ubiquitin Ligases in Cell Cycle Control and Cancer
Novel Substrates of SCF Ubiquitin Ligases in Cell Cycle Control and Cancer
批准号:
7188295
负责人:
MICHELE PAGANO
金额:
$16.9万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-04 至 2008-11-30
关键词:
ApoptosisAreaBindingBiology, OtherBortezomibBoxingCDKN1A geneCancer BiologyCell CycleCell Cycle ProgressionCell Cycle RegulationCell ProliferationCell physiologyCellsClassClinicComplexCyclin EDNA RepairDiseaseElementsEnsureEpithelialF-Box ProteinsGrantGusperimusHumanImmune responseIn VitroLigaseMalignant NeoplasmsMass Spectrum AnalysisMediatingNumbersOncogenicOrphanPharmaceutical PreparationsPharmacologic SubstanceProcessProteasome InhibitorProtein OverexpressionProtein SubunitsProteinsProteolysisProto-OncogenesRNA InterferenceRecruitment ActivityResearchRestRoleSKP Cullin F-Box Protein LigasesScreening procedureSignal Transduction PathwaySpecificitySpeedSystemTestingTherapeuticTimeTissuesTumor Suppressor ProteinsUbiquitinUbiquitin-Conjugating EnzymesUbiquitin-mediated Proteolysis PathwayVariantWorkbaseinhibitor/antagonistinterestmouse modelmulticatalytic endopeptidase complexnoveloncoprotein p21p27 Cell Cycle Proteinp27 Enzyme Inhibitorprotein degradationresponsesmall molecule librariestissue culture
中文摘要
描述(由申请人提供):泛素系统是细胞过程的主要调节机制,其速度、特异性和时间至关重要。泛素介导的关键底物蛋白水解控制细胞周期进程、信号转导途径、分化、凋亡、DNA修复和免疫反应。这一过程是由调控泛素靶向成分和效应蛋白降解引擎组成的多聚体机器介导的。调控成分将泛素靶定为降解蛋白,其本身由几个多聚体元素(例如,SCF泛素连接酶复合物)组成,这些多聚体元素在该过程中贡献了许多固有的特异性。在人类中,有68种SCF连接酶,每一种都有不同的F-box蛋白亚基,通过直接将底物募集到连接酶的其余部分,并最终募集到泛素偶联酶,从而提供特异性。值得注意的是,68个人类SCF泛素连接酶(分别含有F-box蛋白UTrcp, Fbw7和Skp2)中只有3个具有确定的底物,其中许多涉及细胞周期控制。其余65种F-box蛋白被认为是“孤儿”,因为它们的底物仍有待发现。我们最近开发了一种新的免疫纯化策略,可以富集F-box蛋白的底物,然后进行质谱分析。我们将系统地鉴定具有生物学意义的人类孤儿F-box蛋白底物(Specific Aim 1)。由于我们的研究兴趣,我们将特别关注那些我们的初步结果表明参与细胞周期控制和癌症的孤儿F-box蛋白。在目标2中,我们将验证在目标1中确定的生物学上最重要的底物。考虑到SCF连接酶在调节细胞增殖中的关键作用,SCF连接酶通常是癌症相关调控的靶标,并参与致癌转化。因此,从拟议的研究中获得的信息将与癌症生物学和其他增生性疾病直接相关。
英文摘要
DESCRIPTION (provided by applicant): The ubiquitin system is a major regulatory mechanism of cellular processes in which speed, specificity, and timing are critical. Ubiquitin-mediated proteolysis of key substrates controls cell cycle progression, signal transduction pathways, differentiation, apoptosis, DNA repair and the immune response. This process is mediated by a multimeric machine, composed of a regulatory ubiquitin-targeting component and an effector protein degradation engine. The regulatory component, which targets ubiquitin to proteins destined for degradation, is itself composed of several multimeric elements (e.g., the SCF ubiquitin ligase complexes) that contribute much of the specificity inherent in the process. In humans, there are sixty-eight SCF ligases, each characterized by a different F-box protein subunit that provides specificity by directly recruiting the substrate to the rest of the ligase and, ultimately, to the ubiquitin-conjugating enzyme. Notably, only three out of 68 human SCF ubiquitin ligases (containing the F-box proteins UTrcp, Fbw7 and Skp2, respectively) have well-established substrates, many of which are involved in cell cycle control. The remaining 65 F-box proteins are considered as "orphan" since their substrates still await discovery. We have recently developed a novel immunopurification strategy that enriches for substrates of F-box proteins followed by mass spectrometry analysis. We will systematically identify biologically significant substrates of human orphan F-box proteins (Specific Aim 1). Because of our research interest, we will focus particularly on those orphan F-box proteins that our preliminary results suggest to be involved in cell cycle control and cancer. Under Aim 2, we will validate the biologically most significant substrates identified under Aim 1. Given their critical role in regulating cell proliferation, SCF ligases are often the target of cancer- related deregulation and involved in oncogenic transformation. Therefore, the information gained from the proposed studies will be of direct relevance to cancer biology and other proliferative diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of the cell proliferation by CRL ubiquitin ligases
-
批准号:10590637
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2020
-
负责人:MICHELE PAGANO
-
依托单位:
Regulation of the cell proliferation by CRL ubiquitin ligases-diversity supplement
-
批准号:10594747
-
项目类别:
-
资助金额:$5.71万
-
财政年份:2020
-
负责人:MICHELE PAGANO
-
依托单位:
Regulation of the cell proliferation by CRL ubiquitin ligases
-
批准号:10725087
-
项目类别:
-
资助金额:$9.79万
-
财政年份:2020
-
负责人:MICHELE PAGANO
-
依托单位:
Regulation of the cell proliferation by CRL ubiquitin ligases
-
批准号:10379088
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2020
-
负责人:MICHELE PAGANO
-
依托单位:
Regulating centrosome homeostasis through the UPS
-
批准号:9178269
-
项目类别:
-
资助金额:$18.43万
-
财政年份:2016
-
负责人:MICHELE PAGANO
-
依托单位:
F-box proteins: deregulated cell cycle control and proteolysis in cancer
-
批准号:8761279
-
项目类别:
-
资助金额:$22.39万
-
财政年份:2013
-
负责人:MICHELE PAGANO
-
依托单位:
Role of the SCF/FBX011 ubiquitin ligase in the control of cell proliferation
-
批准号:8325492
-
项目类别:
-
资助金额:$5.34万
-
财政年份:2011
-
负责人:MICHELE PAGANO
-
依托单位:
Role of the SCF/Fbxo15 ubiquitin ligase in stem cells and cancer biology
-
批准号:8274655
-
项目类别:
-
资助金额:$18.38万
-
财政年份:2011
-
负责人:MICHELE PAGANO
-
依托单位:
Role of the SCF/Fbxo15 ubiquitin ligase in stem cells and cancer biology
-
批准号:8168513
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2011
-
负责人:MICHELE PAGANO
-
依托单位:
Role of the SCF/FBX011 ubiquitin ligase in the control of cell proliferation
-
批准号:8513435
-
项目类别:
-
资助金额:$5.08万
-
财政年份:2011
-
负责人:MICHELE PAGANO
-
依托单位:
Role of the SCF/FBX011 ubiquitin ligase in the control of cell proliferation
-
批准号:8152909
-
项目类别:
-
资助金额:$6.05万
-
财政年份:2011
-
负责人:MICHELE PAGANO
-
依托单位:
Growth Control
-
批准号:7714188
-
项目类别:
-
资助金额:$1.45万
-
财政年份:2008
-
负责人:MICHELE PAGANO
-
依托单位:
Novel Substrates of SCF Ubiquitin Ligases in Cell Cycle Control and Cancer
-
批准号:7382542
-
项目类别:
-
资助金额:$20.3万
-
财政年份:2006
-
负责人:MICHELE PAGANO
-
依托单位:
EXPRESSION OF CELL CYCLE PROTEINS IN BREAST CANCER
-
批准号:2696380
-
项目类别:
-
资助金额:$24.02万
-
财政年份:1998
-
负责人:MICHELE PAGANO
-
依托单位:
F box Proteins and Deregulated Proteolysis in Cancer
-
批准号:6574895
-
项目类别:
-
资助金额:$3.36万
-
财政年份:1998
-
负责人:MICHELE PAGANO
-
依托单位:
Regulation of the G1 Phase by the Ubiquitin Pathway
-
批准号:6881181
-
项目类别:
-
资助金额:$47.36万
-
财政年份:1998
-
负责人:MICHELE PAGANO
-
依托单位:
Regulation of the cell cycle by SCF and APC/C ubiquitin ligases
-
批准号:8106860
-
项目类别:
-
资助金额:$45.6万
-
财政年份:1998
-
负责人:MICHELE PAGANO
-
依托单位:
Regulation of the cell cycle by SCF and APC/C ubiquitin ligases
-
批准号:7258645
-
项目类别:
-
资助金额:$3.13万
-
财政年份:1998
-
负责人:MICHELE PAGANO
-
依托单位:
F-box proteins: deregulated cell cycle control and proteolysis in cancer
-
批准号:7258343
-
项目类别:
-
资助金额:$45.87万
-
财政年份:1998
-
负责人:MICHELE PAGANO
-
依托单位:
Regulation of the cell cycle by SCF and APC/C ubiquitin ligases
-
批准号:8451514
-
项目类别:
-
资助金额:$44.01万
-
财政年份:1998
-
负责人:MICHELE PAGANO
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: